Application note: Next-gen protein sequencing rapid ID of COVID variants
Posted: 24 November 2023 | Quantum-Si | No comments yet
Quantum-Si’s Next-Generation Protein Sequencing technology on Platinum™, rapidly distinguishes SARS-CoV-2 variants based on amino acid sequence.
Accurate and rapid identification of SARS-CoV-2 variants are critical for effective disease monitoring and treatment, particularly in long COVID cases where spike protein remnants may persist in the bloodstream. Utilizing Quantum-Si’s protein sequencing technology on the Platinum™ instrument can distinguish the Alpha, Delta, and Omicron variants based on differences in the amino acid sequence of their Spike proteins. This method could lead to new understandings and treatment of the disease.
Related content from this organisation
Related topics
Biomarkers, Cell Cultures, Covid-19, Genomics, Immunotherapy, Molecular Biology, Protein
Related organisations
Quantum-Si